Skip to Main Content
YSM Home

INFORMATION FOR

DownloadHi-Res Photo

Dieter Lindskog, MD

Associate Professor of Orthopaedics and Rehabilitation; Disease Aligned Research Team Leader, Sarcoma Program, Yale Cancer Center

Contact Information

Dieter Lindskog, MD

Office Location

Mailing Address

  • Orthopaedics & Rehabilitation

    P.O. Box 208071

    New Haven, CT 06520-8071

    United States

Yale Medicine

Patient Care

Are you a patient?Please visit the Yale Medicine website for information about the services we offer and making an appointment.View Doctor Profile

Research Summary

GRANTS:

NIH/NIDDK

I.D.# R24DK092759
Title: Interdisciplinary Study of Marrow Adiposity, Mineral Metabolism & Energy Balance
P.I.: Multiple PIs, D. Lindskog
Percent effort: 1%
Total costs for project period: $4,692,958
Project period: 9/01/11-8/31/20

Extensive Research Description

My cancer related research involves clinical study of patients with malignant and benign bone and soft tissue tumors. My clinical practice is directed nearly full time at the treatment of patients with orthopedic oncologic disease including sarcomas and metastatic disease to bone and as such is rare in the medical field. My clinical investigations include evaluating outcomes for different reconstructive techniques after sarcoma resections, and also for minimally invasive techniques of treating benign bone lesions.

Coauthors

Research Interests

Bone Diseases; Carcinosarcoma; Neoplasm Metastasis

Selected Publications

  • Comparative Outcomes Between Osteosarcoma and Pediatric Soft Tissue Sarcomas Of Bone: A National Cancer Database AnalysisYu K, Cahill S, Toombs C, Lindskog D. Comparative Outcomes Between Osteosarcoma and Pediatric Soft Tissue Sarcomas Of Bone: A National Cancer Database Analysis 2021, 784-786. DOI: 10.1542/peds.147.3_meetingabstract.784.
  • Predictors of Lymph Node Involvement by Soft Tissue Sarcoma: An Analysis of the National Cancer Database (NCDB)Miccio J, Jairam V, Gao S, Augustyn A, Oladeru O, Onderdonk B, Costa J, Han D, Khan S, Friedlaender G, Lindskog D, Deshpande H, Tara H, Osborn H, Roberts K, Patel K. Predictors of Lymph Node Involvement by Soft Tissue Sarcoma: An Analysis of the National Cancer Database (NCDB) International Journal Of Radiation Oncology • Biology • Physics 2018, 102: e335. DOI: 10.1016/j.ijrobp.2018.07.1028.
  • Immuno-oncologic Approach to Musculoskeletal TumorsIbe I, Sahlstrom A, Nguyen M, Lindskog D, Friedlaender G, Lee F. Immuno-oncologic Approach to Musculoskeletal Tumors Techniques In Orthopaedics 2018, 33: 140-147. DOI: 10.1097/bto.0000000000000305.
  • Chapter 204: Megaprostheses for Reconstruction following Tumor Resection about the knee.Lindskog, DM & O’Connor MI; In Insall & Scott: Surgery of the Knee 6th Edition, Elsevier, 2018
  • Bilateral atypical femur fractures without bisphosphonate exposureSzolomayer LK, Ibe IK, Lindskog DM. Bilateral atypical femur fractures without bisphosphonate exposure Skeletal Radiology 2016, 46: 241-247. PMID: 27900455, DOI: 10.1007/s00256-016-2526-0.
  • Leiomyoma of the Foot and Ankle: A Case SeriesSzolomayer LK, Talusan PG, Chan WF, Lindskog DM. Leiomyoma of the Foot and Ankle: A Case Series Foot & Ankle Specialist 2016, 10: 270-273. PMID: 27654461, DOI: 10.1177/1938640016670243.
  • Case of a Missed Giant Cell Tumor of Bone: An Opportunity to Observe its Natural History Disease.Russo GS, Rubio DR, Yacob A, Lindskog DM, Alomari AK, Friedlaender GE. Case of a Missed Giant Cell Tumor of Bone: An Opportunity to Observe its Natural History Disease. Connecticut Medicine 2016, 80: 399-403. PMID: 29782126.
  • Pathologic fractures through benign bone lesions in children and adolescentsCruz A, Lindskog D. Pathologic fractures through benign bone lesions in children and adolescents Current Orthopaedic Practice 2011, 22: 351-361. DOI: 10.1097/bco.0b013e31822327bd.
  • Evaluation of bone mineral density and metabolic abnormalities associated with low-energy hip fracturesOetgen M, Miki R, Smart L, Lindskog D. Evaluation of bone mineral density and metabolic abnormalities associated with low-energy hip fractures Current Orthopaedic Practice 2009, 20: 674-681. DOI: 10.1097/bco.0b013e3181ad4b0c.
  • Orthopaedic Management Improves the Early Rate of Osteoporosis Treatment After Hip Fracture: A Randomized Clinical TrialMiki R, Oetgen M, Kirk J, Insogna K, Lindskog D. Orthopaedic Management Improves the Early Rate of Osteoporosis Treatment After Hip Fracture: A Randomized Clinical Trial Journal Of Clinical Densitometry 2008, 11: 463. DOI: 10.1016/j.jocd.2008.05.069.
  • Musculoskeletal, Integument, BreastMarcus R, DiCaprio M, Lindskog D, McGrath B, Gamble K, Scarborough M. Musculoskeletal, Integument, Breast 2005, 243-269. DOI: 10.1007/3-540-26498-1_16.
  • Intramedullary Versus Extramedullary Fixation for the Treatment of Intertrochanteric Hip FracturesBaumgaertner M, Curtin S, Lindskog D. Intramedullary Versus Extramedullary Fixation for the Treatment of Intertrochanteric Hip Fractures Clinical Orthopaedics And Related Research® 1998, 348: 87-94. PMID: 9553538, DOI: 10.1097/00003086-199803000-00015.
Edit Profile